21/03/2024, Paris, France ERINHA (European Research Infrastructure on Highly Pathogenic Agents) spearheads the EU-funded NAVIPP (New AntiVirals for Infections with Pandemic Potential) project, an ambitious endeavour aimed at fortifying the European Union’s preparedness and response capabilities against viral threats with pandemic potential. NAVIPP represents a collaborative effort among esteemed international research institutions, pharmaceutical entities, and […]

20/03/2024, Paris, France ERINHA (European Research Infrastructure on Highly Pathogenic Agents) is proud to announce its role in co-coordinating the CCHFVACIM project, a groundbreaking collaborative initiative, financed under Horizon Europe, aimed at developing prophylactic and therapeutic countermeasures against the Crimean-Congo Haemorrhagic Fever Virus (CCHFV). CCHFV is a highly threatening vector-borne pathogen with a wide distribution, […]

09/01/2024 Starting this year, the new APPEAL (Antivirus Pandemic Preparedness EuropeAn pLatform) project has been launched to enhancing preparedness for future pandemics. In collaboration with 12 partners from 6 countries, under Jena University Hospital leadership, this EU funded collaboration will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year […]

The EU-funded ERINHA-Advance project has brought together high containment labs capable of working with the most dangerous pathogens on the planet – causing serious disease and having no treatment or vaccines available. The project was completed in the summer of 2022 and is published on the CORDIS website. Developing a comprehensive strategy for long-term sustainability […]